146 related articles for article (PubMed ID: 12781189)
1. D-Phe-Pro-Arg type thrombin inhibitors: unexpected selectivity by modification of the P1 moiety.
Lange UE; Baucke D; Hornberger W; Mack H; Seitz W; Höffken HW
Bioorg Med Chem Lett; 2003 Jun; 13(12):2029-33. PubMed ID: 12781189
[TBL] [Abstract][Full Text] [Related]
2. Novel morpholinone-based D-Phe-Pro-Arg mimics as potential thrombin inhibitors: design, synthesis, and X-ray crystal structure of an enzyme inhibitor complex.
Dahlgren A; Johansson PO; Kvarnström I; Musil D; Nilsson I; Samuelsson B
Bioorg Med Chem; 2002 Jun; 10(6):1829-39. PubMed ID: 11937341
[TBL] [Abstract][Full Text] [Related]
3. Novel non-covalent thrombin inhibitors incorporating P(1) 4,5,6,7-tetrahydrobenzothiazole arginine side chain mimetics.
Marinko P; Krbavcic A; Mlinsek G; Solmajer T; Bakija AT; Stegnar M; Stojan J; Kikelj D
Eur J Med Chem; 2004 Mar; 39(3):257-65. PubMed ID: 15051174
[TBL] [Abstract][Full Text] [Related]
4. Molecular design and characterization of an alpha-thrombin inhibitor containing a novel P1 moiety.
Malikayil JA; Burkhart JP; Schreuder HA; Broersma RJ; Tardif C; Kutcher LW; Mehdi S; Schatzman GL; Neises B; Peet NP
Biochemistry; 1997 Feb; 36(5):1034-40. PubMed ID: 9033393
[TBL] [Abstract][Full Text] [Related]
5. Exploring the chiral space within the active site of alpha-thrombin with a constrained mimic of D-Phe-Pro-Arg--design, synthesis, inhibitory activity, and X-ray structure of an enzyme-inhibitor complex.
Hanessian S; Balaux E; Musil D; Olsson LL; Nilsson I
Bioorg Med Chem Lett; 2000 Feb; 10(3):243-7. PubMed ID: 10698445
[TBL] [Abstract][Full Text] [Related]
6. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity study of tripeptide thrombin inhibitors using alpha-alkyl amino acids and other conformationally constrained amino acid substitutions.
Shuman RT; Rothenberger RB; Campbell CS; Smith GF; Gifford-Moore DS; Paschal JW; Gesellchen PD
J Med Chem; 1995 Oct; 38(22):4446-53. PubMed ID: 7473571
[TBL] [Abstract][Full Text] [Related]
8. Structural modification of an orally active thrombin inhibitor, LB30057: replacement of the D-pocket-binding naphthyl moiety.
Lee K; Hwang SY; Hong S; Hong CY; Lee CS; Shin Y; Kim S; Yun M; Yoo YJ; Kang M; Oh YS
Bioorg Med Chem; 1998 Jun; 6(6):869-76. PubMed ID: 9681152
[TBL] [Abstract][Full Text] [Related]
9. Novel thrombin inhibitors incorporating non-basic partially saturated heterobicyclic P1-arginine mimetics.
Peterlin-Masic L; Mlinsek G; Solmajer T; Trampus-Bakija A; Stegnar M; Kikelj D
Bioorg Med Chem Lett; 2003 Mar; 13(5):789-94. PubMed ID: 12617892
[TBL] [Abstract][Full Text] [Related]
10. Enzyme binding selectivity prediction: alpha-thrombin vs trypsin inhibition.
Mlinsek G; Novic M; Kotnik M; Solmajer T
J Chem Inf Comput Sci; 2004; 44(5):1872-82. PubMed ID: 15446847
[TBL] [Abstract][Full Text] [Related]
11. Peptides and pseudopeptides incorporating D-Phe-Pro-Arg and Arg-Gly-Asp lead sequences as potential antithrombotic agents.
Ilas J; Hudecz F; Süli-Vargha H; Kikelj D
J Pept Sci; 2008 Aug; 14(8):946-53. PubMed ID: 18383437
[TBL] [Abstract][Full Text] [Related]
12. New inhibitors of thrombin and other trypsin-like proteases: hydrogen bonding of an aromatic cyano group with a backbone amide of the P1 binding site replaces binding of a basic side chain.
Lee SL; Alexander RS; Smallwood A; Trievel R; Mersinger L; Weber PC; Kettner C
Biochemistry; 1997 Oct; 36(43):13180-6. PubMed ID: 9341205
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of selective boron-containing thrombin inhibitors.
Wienand A; Ehrhardt C; Metternich R; Tapparelli C
Bioorg Med Chem; 1999 Jul; 7(7):1295-307. PubMed ID: 10465405
[TBL] [Abstract][Full Text] [Related]
14. Structure-based understanding of ligand affinity using human thrombin as a model system.
Nienaber VL; Mersinger LJ; Kettner CA
Biochemistry; 1996 Jul; 35(30):9690-9. PubMed ID: 8703940
[TBL] [Abstract][Full Text] [Related]
15. Highly selective mechanism-based thrombin inhibitors: structures of thrombin and trypsin inhibited with rigid peptidyl aldehydes.
Krishnan R; Zhang E; Hakansson K; Arni RK; Tulinsky A; Lim-Wilby MS; Levy OE; Semple JE; Brunck TK
Biochemistry; 1998 Sep; 37(35):12094-103. PubMed ID: 9724521
[TBL] [Abstract][Full Text] [Related]
16. Discovery of benzothiazole guanidines as novel inhibitors of thrombin and trypsin IV.
Karle M; Knecht W; Xue Y
Bioorg Med Chem Lett; 2012 Jul; 22(14):4839-43. PubMed ID: 22726924
[TBL] [Abstract][Full Text] [Related]
17. Design of potent bivalent thrombin inhibitors based on hirudin sequence: incorporation of nonsubstrate-type active site inhibitors.
Tsuda Y; Cygler M; Gibbs BF; Pedyczak A; Féthière J; Yue SY; Konishi Y
Biochemistry; 1994 Dec; 33(48):14443-51. PubMed ID: 7981204
[TBL] [Abstract][Full Text] [Related]
18. Benzyloxycarbonyl-D-Phe-Pro-methoxypropylboroglycine: a novel inhibitor of thrombin with high selectivity containing a neutral side chain at the P1 position.
Claeson G; Philipp M; Agner E; Scully MF; Metternich R; Kakkar VV; DeSoyza T; Niu LH
Biochem J; 1993 Mar; 290 ( Pt 2)(Pt 2):309-12. PubMed ID: 8452516
[TBL] [Abstract][Full Text] [Related]
19. Rational design and characterization of D-Phe-Pro-D-Arg-derived direct thrombin inhibitors.
Figueiredo AC; Clement CC; Zakia S; Gingold J; Philipp M; Pereira PJ
PLoS One; 2012; 7(3):e34354. PubMed ID: 22457833
[TBL] [Abstract][Full Text] [Related]
20. Azaindoles: moderately basic P1 groups for enhancing the selectivity of thrombin inhibitors.
Sanderson PE; Stanton MG; Dorsey BD; Lyle TA; McDonough C; Sanders WM; Savage KL; Naylor-Olsen AM; Krueger JA; Lewis SD; Lucas BJ; Lynch JJ; Yan Y
Bioorg Med Chem Lett; 2003 Mar; 13(5):795-8. PubMed ID: 12617893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
